Caerus Health - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 218,912 | 232,708 | 444,887 | 735,374 | 630,671 | 584,294 | 550,713 | 628,373 |
| Profit before tax | - | - | - | - | - | - | 329,253 | 356,127 |
| Net profit | 96,527 | 119,777 | 181,521 | 156,989 | 212,360 | 301,445 | 276,027 | 297,665 |
| Equity | 128,916 | 158,693 | 64,214 | 221,203 | 253,564 | 335,009 | 331,035 | 162,028 |
| Liabilities | 38,197 | 51,311 | 131,537 | 369,526 | 251,638 | 122,875 | 54,006 | 50,203 |
| Non-current assets | 913 | 435 | 102 | 2 | 0 | 0 | 0 | 0 |
| Current assets | 166,152 | 209,422 | 199,639 | 598,351 | 505,015 | 456,403 | 385,852 | 214,712 |
| Total assets | 167,065 | 209,857 | 199,741 | 598,353 | 505,015 | 456,403 | 385,852 | 214,712 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 146,448 | 173,797 | 227,862 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +86.5% | +6.3% | +91.2% | +65.3% | -14.2% | -7.4% | -5.7% | +14.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 57.8% | 57.1% | 90.9% | 26.2% | 42.1% | 66.0% | 71.5% | 138.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 74.9% | 75.5% | 282.7% | 71.0% | 83.8% | 90.0% | 83.4% | 183.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 44.1% | 51.5% | 40.8% | 21.3% | 33.7% | 51.6% | 50.1% | 47.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 59.8% | 56.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 2.0 | 1.7 | 1.0 | 0.4 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 54,728 | 58,177 | 111,222 | 183,844 | 222,592 | 292,147 | 275,357 | 314,187 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Caerus Health - Social security debts
The company had no debts to Sodra
Caerus Health - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-02 | 2025-03-06 | 3066.93 |
| 2025-02-28 | 2025-03-01 | 3165.98 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Caerus Health, UAB (code 303179928) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €628.4K and net profit of €297.7K, giving a profit margin of 47.4%. Revenue increased by 14.1% year on year and by 7.5% over two years, after moving from €584.3K in 2023 to €550.7K in 2024 and then rebounding in 2025. Net profit followed a similar pattern, declining from €301.4K in 2023 to €276.0K in 2024 before rising again in 2025. At year-end 2025, total assets stood at €214.7K, equity at €162.0K and liabilities at €50.2K. The balance sheet remains lightly leveraged, with debt-to-equity at 0.31 and an equity ratio of 75.5%. Asset turnover was 2.93x, indicating efficient use of assets relative to revenue. Revenue per employee was €314.2K and profit per employee was €148.8K. Return indicators were exceptionally strong in 2025, reflecting the company’s relatively small equity base.